Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation
Red blood cells (RBCs) are an excellent choice for cell preparation research because of their biocompatibility, high drug loading, and long half-life. In this study, doxorubicin (DOX) was encapsulated with RBCs as the carrier. The biotin-avidin system binding principle was used to modify biotinylate...
Saved in:
Main Authors: | Chen Wang (Author), Min Wang (Author), Yan Zhang (Author), Hongxin Jia (Author), Binbin Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine-Glycine-Aspartate) Strategies
by: Bojana Bogdanović, et al.
Published: (2024) -
Multicomponent crystals: Solubility enhancement of simvastatin using arginine and glycine coformers
by: Iyan Sopyan, et al.
Published: (2024) -
Solubility enhancement of carvedilol by multicomponent crystal approach using glycine and arginine as coformers
by: Iyan Sopyan, et al.
Published: (2023) -
A rare but treatable inborn error of metabolism: Arginine:glycine amidinotransferase (AGAT) deficiency
by: Sebastian Romeo Pintilie, et al.
Published: (2022) -
Synthesis and characterization of a glycine- modified heptamethine indocyanine dye for in vivo cancer-targeted near-infrared imaging
by: Liu T, et al.
Published: (2014)